Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
03/2003
03/05/2003CN1400505A Image forming material and ammonium compound
03/04/2003US6528530 Side effect reduction; mainly the D-threo stereoisomer of a phenidate
03/04/2003US6528529 Compounds with activity on muscarinic receptors
03/04/2003CA2218913C Substituted oximes, hydrazones and olefins as neurokinin antagonists
02/2003
02/28/2003CA2399567A1 Crystalline material
02/27/2003WO2003016278A1 Process for preparation of piperidin-2-ylacetic acid
02/27/2003WO2003016274A2 2-substituted piperidines that are ligands for monoamine receptors and transporters
02/27/2003WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes
02/27/2003WO2002102777A3 NOVEL CRYSTALLINE FORMS OF 4-[4-[4-(HYDROXYDIPHENYLMETHYL)-1-PIPERINDINYL]-1-HYDROXYBUTYL]-α, α-DIMETHYLBENZENE ACETIC ACID AND ITS HYDROCHLORIDE
02/27/2003WO2002092588A3 Aromatic sulfone hydroxamates and their use as protease inhibitors
02/27/2003WO2002083641A3 Amino-aza-cyclohexanes for the treatment of malaria
02/27/2003WO2002079149A3 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
02/27/2003WO2002074050A3 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor
02/27/2003WO2002067869A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists
02/27/2003WO2002060388A3 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
02/27/2003WO2002046157A3 Methods for the stereoselective synthesis of substituted piperidines
02/27/2003WO2002017919A3 Use of threo-methylphenidate compounds to enhance memory
02/27/2003US20030040532 Methods for treating dementia due to HIV disease
02/27/2003US20030040530 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containning them
02/26/2003EP1285917A1 Process for producing carbostyril derivative
02/26/2003EP1285655A1 Stabilized pharmaceutical compositions containing calcium channel blockers
02/26/2003EP1284966A2 Process for the synthesis of amine ethers from secondary amino oxides
02/26/2003EP1284961A1 Glycinamides
02/26/2003EP1284954A1 Method for the production of esters of unsaturated carboxylic acids
02/26/2003EP1284730A1 Aralkyl ester soft drugs
02/26/2003EP1042297B1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
02/26/2003EP0938483B1 Muscarinic antagonists
02/26/2003EP0798295B1 Novel amidinonaphthyl derivative or salt thereof
02/26/2003CN1399622A Triphenylalkene derivatives and their use as selective estrogen receptor modulators
02/25/2003US6525215 HIV protease inhibitors
02/25/2003US6525202 Cyclic amine phenyl beta-3 adrenergic receptor agonists
02/25/2003US6525199 Ring coupling, reduction and deprotecting; synthesis of compounds for alleviation and treatment of symptoms due to ischemic diseases
02/25/2003US6525077 Cyanoguanidine prodrugs
02/25/2003US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists
02/25/2003US6525069 Such as N-(t-butyl)-N'-(2-((3-(4-fluorophenyl)methyl)piperi -dinyl)methyl)cyclohexyl)urea; prevention of asthma and other allergic diseases
02/25/2003US6525052 Compounds useful as reversible inhibitors of cysteine proteases
02/25/2003US6525042 Sulfonyl derivatives
02/25/2003US6525036 Compounds and compositions as protease inhibitors
02/25/2003US6525020 For drug delivery
02/20/2003WO2003014085A1 Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride
02/20/2003WO2003014084A1 Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
02/20/2003WO2003014072A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands
02/20/2003WO2003013531A1 Phenyl derivatives as factor xa inhibitors
02/20/2003WO2003013528A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists.
02/20/2003WO2003013527A1 Sulfonamide derivatives as gamma secretase inhibitors
02/20/2003WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
02/20/2003WO2002100829A3 Process for the preparation of paroxetine substantially free of alkoxy impurities
02/20/2003WO2002068387A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists
02/20/2003US20030036659 Method for the production of n-alkenyl amides
02/20/2003US20030036654 Useful as mediators of protein-protein interactions
02/20/2003US20030036553 Use of (+)-a-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis
02/20/2003US20030036552 Novel compounds
02/20/2003DE20217957U1 Oxidative dyeing agent for keratin fibers uses 2-aminomethylene-substituted resorcinols as couplers, some of which are novel compounds
02/20/2003CA2457814A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands
02/20/2003CA2455871A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists.
02/20/2003CA2455861A1 Sulfonamide derivatives as gamma secretase inhibitors
02/19/2003EP1283827A2 Caspase inhibitors and uses thereof
02/19/2003EP1144360A4 A method for the synthesis of compounds of formula 1 and derivatives thereof
02/19/2003EP0979818B1 Benzoic acid compounds and medicinal use thereof
02/19/2003EP0863752B1 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
02/19/2003CN1398260A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k
02/19/2003CN1398252A Dehydroamino acids compounds
02/19/2003CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia
02/19/2003CN1397550A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them
02/19/2003CN1397547A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them
02/19/2003CN1101815C 3-aminochromanylsulfonyl (thio) ureas, processes for their prepn. their use, and pharmaceutical prepn. comprising them
02/19/2003CN1101810C Process for prepn. of lercanidipine hydrochloride
02/18/2003US6521758 Tosylate salts of 4-(p-fluorophenyl)-piperidine-3-carbinols
02/18/2003US6521666 Inhibitors of α4 mediated cell adhesion
02/18/2003US6521650 Amines as pharmaceutical agents
02/18/2003US6521621 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
02/18/2003US6521619 Bind to the interaction-domain of integrin lfa-1 interrupting enothelial cell-leukocyte adhesion
02/18/2003US6521592 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
02/18/2003CA2243542C Resolution of threo-methylphenidate
02/13/2003WO2003011858A1 Substituted isoindoles and e use thereof
02/13/2003WO2003011851A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
02/13/2003WO2003011295A1 Fexofenadine polymorph
02/13/2003WO2002076988A3 Tert. alkylphenoxy substituted polycyclic compounds
02/13/2003US20030032835 Process for the preparation of 2,5-bis-(2,2,2-trifluoroethoxy)-N-(2-piperidylmethyl)-benzamide (FLECAINIDE)
02/13/2003US20030032810 Antagonists of natural killer cell-3 receptors
02/13/2003US20030032806 Performed at lower temperature
02/13/2003US20030032803 Novel amide derivatives as inhibitors of matrix metalloproteinases, TNF-alpha, and aggrecanase
02/13/2003US20030032654 Useful for the treatment or prevention of asthma and other allergic diseases.
02/13/2003CA2455772A1 Substituted isoindoles and their use
02/13/2003CA2449804A1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
02/12/2003EP1283201A1 Process for the preparation of 2,5-bis-(2,2,2-trifluoroethoxy)-n-(2-piperidyl-methyl)-benzamide (flecanide)
02/12/2003EP1283200A2 Optically pure paroxetine precursors
02/12/2003EP1282630A1 Hydroxylamine esters as polymerization initiators
02/12/2003EP1282616A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain
02/12/2003EP0976733B1 Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof
02/12/2003EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
02/12/2003CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease
02/11/2003US6518314 Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions
02/11/2003US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
02/11/2003US6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
02/11/2003US6518286 Compounds
02/11/2003US6518284 4-substituted piperidines
02/11/2003US6518282 4-Arylpiperidine derivatives for the treatment of pruritus
02/11/2003US6518272 HT3 receptor agonists and antagonists; treatment of anxiety, depression, cognitive deficits, and prostate cancer
02/11/2003CA2250391C Butadiene derivatives and process for their preparation